Axon Enterprise (AXON) Slides On Mixed Valuation Views, Is It Still 31% Undervalued?
Axon Enterprise (AXON) has drawn investor attention after recent share performance, with the stock down 22% over the past month and 15% year to date, compared with a 3 year total return above 130%.
Recent trading tells a mixed story for Axon Enterprise, with the share price down 21.8% over the past month and 14.9% year to date. At the same time, the 3 year total shareholder return of 132.5% and 5 year total shareholder return of 178.1% still point to a strong longer run for investors who held through the swings.
Scan beyond Axon Enterprise and compare this pullback with hand picked peers by checking stocks on the 11 resilient stocks with low risk scores that combine resilience with lower risk scores.
Axon Enterprise now sits at a crossroads. Does the recent slide reflect cracks in the public safety business, or is sentiment resetting while the valuation story stays intact?
Most Popular Narrative: 30.9% Undervalued
On the most followed narrative, Axon Enterprise screens as meaningfully below its implied fair value of $693.40 compared with the last close at $479.34, which puts a spotlight on the assumptions doing the heavy lifting behind that gap.
Fast-track adoption of new Axon products such as Draft One (AI), TASER 10, Axon Body 4, and Dedrone (counter-drone) is driving up average deal values and product bundles per customer, raising net revenue per user and supporting higher long-term margins as the ecosystem deepens.
Want to see what kind of revenue trajectory and profit profile are being baked into that valuation gap? The narrative leans on rapid subscription expansion, richer hardware and software bundles, and a future earnings multiple that assumes Axon Enterprise keeps compounding its public safety platform story in a big way.
Result: Fair Value of $693.40 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, Axon Enterprise faces real pressure points if government budgets tighten or regulators clamp down on surveillance and AI tools, which could undercut the bullish narrative.
Find out about the key risks to this Axon Enterprise narrative.
Another View On Axon Enterprise Valuation
The analyst narrative leans on a rich future earnings multiple to argue Axon Enterprise looks 30.9% undervalued against a fair value of $693.40. A contrasting read comes from the SWS DCF model, which pegs future cash flow value at $443.03, below the current $479.34, implying Axon Enterprise trades above that cash flow anchor. Which lens do you trust more: the long term cash generation or the premium earnings story?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Axon Enterprise for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 31 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Mixed messages on Axon Enterprise so far? If you want to move quickly and shape your own view, start by checking the balance of 2 key rewards and 3 important warning signs
Looking for more investment ideas beyond Axon Enterprise?
If Axon Enterprise has your attention, do not stop there. Use the Simply Wall St Screener to line up fresh stock ideas before the market moves without you.
- Target value first by scanning companies that combine quality fundamentals with attractive prices through the 31 high quality undervalued stocks.
- Strengthen your downside protection by focusing on businesses that carry sturdier finances using the list of solid balance sheet and fundamentals (23 results).
- Hunt for overlooked opportunities that have not yet hit the spotlight by checking the 15 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com